229 related articles for article (PubMed ID: 9832639)
1. Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy.
Matsuda M; Shikata K; Wada J; Sugimoto H; Shikata Y; Kawasaki T; Makino H
Nephron; 1998 Dec; 80(4):408-13. PubMed ID: 9832639
[TBL] [Abstract][Full Text] [Related]
2. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.
Endo M; Ohi H; Ohsawa I; Fujita T; Matsushita M; Fujita T
Nephrol Dial Transplant; 1998 Aug; 13(8):1984-90. PubMed ID: 9719152
[TBL] [Abstract][Full Text] [Related]
3. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.
Hisano S; Matsushita M; Fujita T; Endo Y; Takebayashi S
Am J Kidney Dis; 2001 Nov; 38(5):1082-8. PubMed ID: 11684563
[TBL] [Abstract][Full Text] [Related]
4. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
[TBL] [Abstract][Full Text] [Related]
5. Glomerular deposition of mannose-binding lectin in human glomerulonephritis.
Lhotta K; Würzner R; König P
Nephrol Dial Transplant; 1999 Apr; 14(4):881-6. PubMed ID: 10328463
[TBL] [Abstract][Full Text] [Related]
6. Regulation of in situ complement activation via the lectin pathway in patients with IgA nephropathy.
Endo M; Ohi H; Satomura A; Hidaka M; Ohsawa I; Fujita T; Kanmatsuse K; Matsushita M; Fujita T
Clin Nephrol; 2001 Mar; 55(3):185-91. PubMed ID: 11316237
[TBL] [Abstract][Full Text] [Related]
7. Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis.
Hisano S; Matsushita M; Fujita T; Iwasaki H
Am J Kidney Dis; 2005 Feb; 45(2):295-302. PubMed ID: 15685507
[TBL] [Abstract][Full Text] [Related]
8. Human IgA activates the complement system via the mannan-binding lectin pathway.
Roos A; Bouwman LH; van Gijlswijk-Janssen DJ; Faber-Krol MC; Stahl GL; Daha MR
J Immunol; 2001 Sep; 167(5):2861-8. PubMed ID: 11509633
[TBL] [Abstract][Full Text] [Related]
9. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
[TBL] [Abstract][Full Text] [Related]
10. Collectin11 and Complement Activation in IgA Nephropathy.
Wei M; Guo WY; Xu BY; Shi SF; Liu LJ; Zhou XJ; Lv JC; Zhu L; Zhang H
Clin J Am Soc Nephrol; 2021 Dec; 16(12):1840-1850. PubMed ID: 34615657
[TBL] [Abstract][Full Text] [Related]
11. The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides With Glomerular IgA Deposition.
Ma Y; Chen L; Xu Y; Han Q; Yu B; Zhao J; Hua Z; Yang Y; Chen J; Han F
Appl Immunohistochem Mol Morphol; 2020; 28(10):e87-e93. PubMed ID: 31789820
[TBL] [Abstract][Full Text] [Related]
12. [Mannose-binding protein gene polymorphism influences the patterns of glomerular immune deposition in IgA nephropathy].
Gong R; Liu Z; Chen Z; Liu D; Li L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):83-7. PubMed ID: 11295122
[TBL] [Abstract][Full Text] [Related]
13. Complement activation through the lectin pathway in patients with Henoch-Schönlein purpura nephritis.
Endo M; Ohi H; Ohsawa I; Fujita T; Matsushita M
Am J Kidney Dis; 2000 Mar; 35(3):401-7. PubMed ID: 10692265
[TBL] [Abstract][Full Text] [Related]
14. Jak3 expression in glomerular epithelia of IgA nephropathy (IgA-N) patients.
Takahashi T; Shirasawa T; Miyake K; Yahagi Y; Matsumura O; Abe A; Natori Y; Yamabe H; Utsunomiya Y; Maruyama N; Mitarai T; Sakai O
Clin Exp Immunol; 1996 Jun; 104(3):517-24. PubMed ID: 9099938
[TBL] [Abstract][Full Text] [Related]
15. Role of complement in IgA nephropathy.
Daha MR; van Kooten C
J Nephrol; 2016 Feb; 29(1):1-4. PubMed ID: 26567162
[TBL] [Abstract][Full Text] [Related]
16. [Clinico-pathological characteristics and prognosis of IgA nephropathy patients with microalbuminuria and deposition of complement C3].
Guo ZY; Zhou SG; Wang YY; Li X; Xu Y; Du XY; Zhang W; Wu YM
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(9):707-11. PubMed ID: 27055509
[TBL] [Abstract][Full Text] [Related]
17. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy.
Miyazaki R; Kuroda M; Akiyama T; Otani I; Tofuku Y; Takeda R
Clin Nephrol; 1984 Jun; 21(6):335-40. PubMed ID: 6205804
[TBL] [Abstract][Full Text] [Related]
18. Predictors of prognosis in IgA nephropathy.
Tomino Y
Kaohsiung J Med Sci; 2012 Oct; 28(10):517-20. PubMed ID: 23089315
[TBL] [Abstract][Full Text] [Related]
19. Significance of glomerular deposition of C3c and C3d in IgA nephropathy.
Nakagawa H; Suzuki S; Haneda M; Gejyo F; Kikkawa R
Am J Nephrol; 2000; 20(2):122-8. PubMed ID: 10773612
[TBL] [Abstract][Full Text] [Related]
20. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
Segarra A
Nefrologia; 2010; 30(5):501-7. PubMed ID: 20882091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
